BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19960273)

  • 1. Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours.
    Volante M; Papotti M
    Endocr Pathol; 2010 Mar; 21(1):1-6. PubMed ID: 19960273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The story of poorly differentiated thyroid carcinoma: From Langhans' description to the Turin proposal via Juan Rosai.
    Volante M; Bussolati G; Papotti M
    Semin Diagn Pathol; 2016 Sep; 33(5):277-83. PubMed ID: 27344303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated thyroid carcinoma.
    Xu B; Ghossein R
    Semin Diagn Pathol; 2020 Sep; 37(5):243-247. PubMed ID: 32360274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural features of solid/trabecular areas in differentiated thyroid carcinoma.
    Massi D; Santucci M; Bianchi S; Vezzosi V; Zampi G
    Ultrastruct Pathol; 2001; 25(1):13-20. PubMed ID: 11297315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
    Akaishi J; Kondo T; Sugino K; Ogimi Y; Masaki C; Hames KY; Yabuta T; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Katoh R; Ito K
    World J Surg; 2019 Sep; 43(9):2235-2244. PubMed ID: 31098668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
    Volante M; Collini P; Nikiforov YE; Sakamoto A; Kakudo K; Katoh R; Lloyd RV; LiVolsi VA; Papotti M; Sobrinho-Simoes M; Bussolati G; Rosai J
    Am J Surg Pathol; 2007 Aug; 31(8):1256-64. PubMed ID: 17667551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature.
    Saglietti C; Onenerk AM; Faquin WC; Sykiotis GP; Ziadi S; Bongiovanni M
    Cytopathology; 2017 Dec; 28(6):467-474. PubMed ID: 29094425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.
    Asioli S; Erickson LA; Righi A; Jin L; Volante M; Jenkins S; Papotti M; Bussolati G; Lloyd RV
    Mod Pathol; 2010 Sep; 23(9):1269-78. PubMed ID: 20562850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine needle aspiration cytology features of poorly differentiated thyroid carcinoma.
    Purkait S; Agarwal S; Mathur SR; Jain D; Iyer VK
    Cytopathology; 2016 Jun; 27(3):176-84. PubMed ID: 26662642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated thyroid carcinoma: a cytologic-histologic review.
    Bongiovanni M; Sadow PM; Faquin WC
    Adv Anat Pathol; 2009 Sep; 16(5):283-9. PubMed ID: 19700938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
    Thyroid; 2019 Sep; 29(9):1255-1261. PubMed ID: 31397224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thyroid carcinoma--differentiated, poorly differentiated and anaplastic carcinoma].
    Kakudo K; Bai Y; Li Y; Wakasa T; Mori I
    Nihon Rinsho; 2007 Nov; 65(11):1979-84. PubMed ID: 18018558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
    Dettmer M; Schmitt A; Steinert H; Moch H; Komminoth P; Perren A
    Histopathology; 2012 Jun; 60(7):1045-51. PubMed ID: 22348590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No Longer Well-Differentiated: Diagnostic Criteria and Clinical Importance of Poorly Differentiated/High-Grade Thyroid Carcinoma.
    Cracolici V
    Surg Pathol Clin; 2023 Mar; 16(1):45-56. PubMed ID: 36739166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid.
    Volante M; Cavallo GP; Papotti M
    Endocr Pathol; 2004; 15(4):313-7. PubMed ID: 15681855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: a single-institution study.
    Kane SV; Sharma TP
    Cancer Cytopathol; 2015 Feb; 123(2):82-91. PubMed ID: 25557073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid.
    Nath MC; Erickson LA
    Adv Anat Pathol; 2018 May; 25(3):172-179. PubMed ID: 29351089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
    Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
    PLoS One; 2020; 15(2):e0229264. PubMed ID: 32092093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.